Organization · Venture Capital
Civilization Ventures
Civilization Ventures is a San Francisco-based venture capital firm founded in 2017, specializing in early-stage investments in transformative technologies within healthcare and life sciences. The firm manages over $200 million and focuses on genomics, diagnostics, and digital health.
Overview
What Civilization Ventures does
What Civilization Ventures is
Civilization Ventures is a San Francisco-based venture capital firm founded in 2017, specializing in early-stage investments in transformative technologies within healthcare and life sciences. The firm manages over $200 million and focuses on genomics, diagnostics, and digital health.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- April 29, 2026
Official channels
Find Civilization Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Civilization Ventures as a funder
Investment thesis
Civilization Ventures invests in scientific founders developing innovations in health technology and biology, focusing on genomics, diagnostics, digital health, and synthetic biology. The firm emphasizes preventative, personalized, and regenerative healthcare solutions.
Focus narrative
Civilization Ventures focuses on investing in early-stage companies led by scientific founders who are developing groundbreaking innovations in health technology and biology. Their investment thesis centers on areas such as genomics, diagnostics, digital health, and synthetic biology, providing both capital and resources to support the growth of these companies.
Value beyond capital
Civilization Ventures adds value to its portfolio companies through a combination of capital investment and extensive support resources. The firm emphasizes 'mentor capital,' providing access to a network of advisors and a Fellowship program for PhDs and MDs transitioning into entrepreneurship, which helps scientific founders translate their lab breakthroughs into successful companies.
Terms and economics
- Typical check
- $100,000–$10,000,000
Focus and fit
- Stages
- Seed · Series A
- Sectors
- Genomics · Diagnostics · Digital Health · Synthetic Biology · Healthcare · Biotech
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 70
- Recorded notable exits
- BillionToOne, Omada Health, Foresight Diagnostics, and Rewrite Therapeutics
Portfolio context
Notable portfolio companies include: Foresight Diagnostics: Develops ultrasensitive diagnostics for early cancer detection. Rewrite Therapeutics: Focuses on genome editing technologies aimed at curing diseases. BillionToOne: Innovates in prenatal disease detection and cancer diagnostics through advanced molecular techniques. Omada Health: Offers virtual care solutions to manage chronic conditions, leveraging digital wearables.
Common questions
What to know about Civilization Ventures
Upseed classifies Civilization Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 29, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.